相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Professional Medical Writer Assistance in Oncology Clinical Trials
Ramez Kouzy et al.
ONCOLOGIST (2020)
Association of Industry Sponsorship With Cancer Clinical Trial Accrual
Dario Pasalic et al.
JAMA ONCOLOGY (2020)
New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology
Perrine Janiaud et al.
CANCER TREATMENT REVIEWS (2019)
Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration
Ariadna Tibau et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration
Ariadna Tibau et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Role of industry funders in oncology RCTs published in high-impact journals and its association with trial conclusions and time to publication
F. Liang et al.
ANNALS OF ONCOLOGY (2018)
Evaluating Progression-Free Survival as a Surrogate Outcome for Health-Related Quality of Life in Oncology A Systematic Review and Quantitative Analysis
Bruno Kovic et al.
JAMA INTERNAL MEDICINE (2018)
Do Contemporary Randomized Controlled Trials Meet ESMO Thresholds for Meaningful Clinical Benefit?
J. C. Del Paggio et al.
ANNALS OF ONCOLOGY (2017)
Impact of industry collaboration on randomised controlled trials in oncology
Anne Linker et al.
EUROPEAN JOURNAL OF CANCER (2017)
Delivery of meaningful cancer care: a retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworks
Joseph C. Del Paggio et al.
LANCET ONCOLOGY (2017)
Approvals in 2016: questioning the clinical benefit of anticancer therapies
Christopher M. Booth et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13
Courtney Davis et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13
Courtney Davis et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Clinical benefit, price and approval characteristics of FDA-approved new drugs for treating advanced solid cancer, 2000-2015
A. Vivot et al.
ANNALS OF ONCOLOGY (2017)
The Primary Outcome Is Positive - Is That Good Enough?
Stuart J. Pocock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
An Appraisal of Clinically Meaningful Outcomes Guidelines for Oncology Clinical Trials
Hemanth Kumar et al.
JAMA ONCOLOGY (2016)
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
N. I. Cherny et al.
ANNALS OF ONCOLOGY (2015)
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
Lowell E. Schnipper et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The Strength of Association Between Surrogate End Points and Survival in Oncology A Systematic Review of Trial-Level Meta-analyses
Vinay Prasad et al.
JAMA INTERNAL MEDICINE (2015)
Unintended Consequences of Expensive Cancer Therapeutics-The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity The John Conley Lecture
Tito Fojo et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2014)
High Cancer Drug Prices in the United States: Reasons and Proposed Solutions
Hagop Kantarjian et al.
JOURNAL OF ONCOLOGY PRACTICE (2014)
Randomized controlled trials in the era of molecular oncology: methodology, biomarkers, and end points
A. Kay et al.
ANNALS OF ONCOLOGY (2012)
Progression-Free Survival: Meaningful or Simply Measurable?
Christopher M. Booth et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Reporting of Serious Adverse Drug Reactions of Targeted Anticancer Agents in Pivotal Phase III Clinical Trials
Bostjan Seruga et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Absolute benefits of medical therapies in phase III clinical trials for breast and colorectal cancer
B. Seruga et al.
ANNALS OF ONCOLOGY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The uncertainty principle and industry-sponsored research
B Djulbegovic et al.
LANCET (2000)
分享论文
